narcolepsy
Advertisement
The FDA has approved LUMRYZ for the treatment of cataplexy or EDS in patients 7 years of age and older with narcolepsy.
The renowned Dr. Emanuel Mignot spoke about the importance of personalized care for persons living with narcolepsy.
Matt Davis, MD, compared current therapies in narcolepsy and provides key takeaways from the WUN gala.
Dr. Sanjeev Kothare spoke about recent advancements, as well as challenges in narcolepsy care.
Dr. Michael Strunc speaks about recent advancements in narcolepsy care, and treatment gaps that still need to be filled.
Richard Kim of Avadel talks about the "exciting" future of narcolepsy care.
Jennifer Gudeman talks about the significance of the WUN Shadows to Light gala and role Avadel plays in treating narcolepsy.
Dr. Anne Marie Morse details all aspects of Wake Up Narcolepsy's inaugural Shadows To Light Gala.
Dr. Anne Marie Morse discusses the challenges of treating children and adolescents with narcolepsy.
Dr. Anne Marie Morse, who was in attendance at SLEEP 2024, recapped the most notable research from the event.
Dr. Anne Marie Morse and co-host continue their discussion with retired NFL player Josh Andrews on his narcolepsy diagnosis.
Dr. Anne Marie Morse and co-host Matthew Allard speak with ex-NFL player Josh Andrews about how narcolepsy affects his life.
A study identified attributes driving treatment preference in caregivers of pediatric patients with narcolepsy.
H1N1 and influenza B viruses may trigger narcolepsy with cataplexy.
In the phase 3 REST-ON study, researchers evaluated the safety and efficacy of FT218, a novel once-nightly sodium ...
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.